In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials ...

A Charleston woman was always short of breath and suffered from an undertreated heart problem. A new device at MUSC has her ...

In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid Can ...

Joy Milne is a "super smeller" with a hyper-sensitive sense of smell, which allowed her to detect her husband's Parkinson's ...

A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.

So far, UX701 has shown encouraging data for Wilson disease ... could be the first treatment option that addresses the ...

The symptoms include general fatigue and weakness, frequent urination, and Symptoms specific to underlying conditions, such as muscle weakness in Wilson's disease. “Chronic hyperuricemia can lead to ...

A brain mapping study funded by the NIH reveals which cell types may be the first to be affected. New research funded by the ...

Meanwhile, it contends, Wilson disease patients have a very wide range of symptoms, so zeroing in on neurological symptoms only may not provide a complete picture of the drug's effects.

Feeling lonely increased risk for all-cause dementia by 31 percent and cognitive impairment by 15 percent. Loneliness is a ...